THE GOLD STANDARD IN THIRD-PARTY CERTIFICATION AND TESTING : +1-800-920-6605, info@bscg.org
Oct 12, 2026
Supplement potency testing is widely available for supplement companies, with one important condition. For vitamins, minerals, amino acids, fatty acids, and botanical markers with published methods, ISO/IEC 17025 accredited contract laboratories run established assays on routine timelines. The difficulty rises when a product contains a novel botanical, a proprietary blend, a live probiotic, or an ingredient with no published validated method. In those cases, the laboratory may need to develop or adapt a method before it can report a reliable result, which adds cost and time.
The practical question for a brand is not whether testing exists. It is whether a scientifically valid method exists for each ingredient in the finished product, and whether the laboratory can apply it to that specific formula. U.S. regulation requires brands to answer that question. FDA's dietary supplement GMP rule at 21 CFR 111.75 requires manufacturers to verify that finished batches meet specifications for identity, purity, strength, and composition using appropriate, scientifically valid methods.
Supplement potency testing is laboratory analysis that measures the actual amount of an active ingredient in a dietary supplement and compares it to the amount declared on the label. It uses quantitative methods such as HPLC, LC-MS/MS, ICP-MS, or microbial plate counts. Results confirm whether a product delivers the labeled strength per serving.
Access to potency testing divides into two tiers. The first tier covers ingredients with compendial or official methods, where testing is a routine service. The second tier covers ingredients that require custom analytical work, where access depends on laboratory expertise, reference standards, and budget.
Standards bodies work to close these gaps. AOAC International publishes Standard Method Performance Requirements for specific supplement analytes, and the United States Pharmacopeia maintains monographs and is developing an LC-MS general chapter for water-soluble vitamins. When a method exists in one of these sources, accredited laboratories can run it. When no method exists, the brand funds the gap.
FDA requires potency verification. It does not prescribe a specific test or instrument. Under 21 CFR Part 111, a manufacturer must establish finished product specifications for identity, purity, strength, composition, and contaminant limits. It must then verify those specifications by testing every finished batch, or by testing a subset of batches under a documented, scientifically valid sampling plan, as described in 21 CFR 111.75(c).
Separately, 21 CFR 111.320 requires that laboratory methods be appropriate for their intended use. The FDA Small Entity Compliance Guide explains that firms may use chemical analysis, microscopic examination, or other scientifically valid approaches, provided they document the basis for the choice. The BSCG Certified Quality program frames its label claim verification around these 111.75 specification requirements.
Label accuracy rules add a numeric dimension. Under 21 CFR 101.9(g)(4), added (Class I) vitamins, minerals, and protein must be present at no less than 100 percent of the declared value. Naturally occurring (Class II) nutrients must reach at least 80 percent. The same section states that reasonable excesses of vitamins and minerals over labeled amounts are acceptable within good manufacturing practice.
FDA inspections find gaps here. Warning letters to Formulation Technology, Inc. and Oregon's Wild Harvest, Inc. cited failures to establish strength specifications and reliance on formulation calculations rather than scientifically valid testing. Testing that is easy to obtain only satisfies the rule when the brand also documents why the method fits the product.
A contract manufacturer may supply a Certificate of Analysis (COA) for each batch it produces. This route is the simplest to access because it is built into production. Its limitation is independence. Part 111 allows reliance on a supplier COA only when the firm has qualified the supplier and documented the basis for that reliance. FDA warning letters have cited improper reliance on supplier documentation.
Independent laboratories such as Eurofins, Intertek, and specialty botanical laboratories publish accreditation scopes that include identity, potency, and contaminant testing. ISO/IEC 17025 accreditation means an accreditation body has assessed the laboratory's competence for the specific methods on its scope. Brands should confirm that the specific analyte and method appear on the published scope.
Certification programs bundle potency testing with contaminant screening, document review, and ongoing monitoring. The BSCG Certified Quality program, for example, verifies identity and label claims using methods such as LC-MS, GC-MS, ICP-MS, HPLC, TLC, DNA, or microscopy, as appropriate to the material. All testing takes place in ISO/IEC 17025 accredited laboratories, and the program follows guidance from AOAC, USP, AHPA, NSF/ANSI 173, ICH Q3D, FDA, and other recognized sources. The standard annual panel tests one lot and one or two label markers; brands can add further markers or specifications à la carte.
BSCG also offers à la carte identity and quantification testing for brands that need results without entering a certification program. Other third-party certification programs also exist. Readers should review each program's published scope to confirm whether label claim testing is included. Mention of any provider here does not constitute an endorsement.
Missing validated methods. The regulation requires a scientifically valid method, but it does not create one. For an uncommon botanical or a new branded ingredient, the brand or its ingredient supplier may need to commission method development and validation. BSCG's botanical testing guidance notes that extracts often require chemical methods because anatomical features are absent, and that DNA methods can fail on processed extracts.
Matrix interference. In a multi-ingredient formula, compounds can co-elute or suppress the signal of the target analyte. Laboratories may need to adjust sample preparation or switch to a more selective technique such as LC-MS/MS.
Proprietary blends. A blend listed with one total weight gives the laboratory no target for each component. BSCG has documented how proprietary blends hinder dosage and ingredient verification. Verifying individual amounts requires the brand to disclose component quantities to the laboratory, since the label alone provides no target. Labels can also list ingredients under multiple chemical names or extract aliases, so the brand should confirm ingredient identity before setting a potency target.
Live organisms. Probiotic potency means viable colony-forming units (CFU) through the end of shelf life, not only at manufacture. Verification requires strain-level identity, enumeration methods validated for the specific matrix, and stability data. BSCG's probiotic quality resource explains that high native microbial loads also make contaminant detection more complex in these products.
Protein products present a related challenge. Standard nitrogen-based protein tests cannot distinguish intact protein from added free amino acids, so verifying a protein claim may require total nitrogen, bound amino acid, and free amino acid testing together.
Published, supplement-specific price lists for potency assays are scarce. BSCG and other providers quote per engagement because the price depends on the analyte, the matrix, the method, and whether validation work is required. Published guidance and laboratory materials indicate that method development and validation add cost and time beyond running an established method, but public data quantifying the difference is limited. Brands should request quotes that separate routine testing from any one-time development fees.
Turnaround follows the same logic. Routine panels at large laboratories can return results within days. Programs that combine potency with contaminant and document review take longer. BSCG states that Certified Quality testing typically completes within 20 business days after sample receipt, with the full certification timeline depending on the brand's document readiness and GMP status.
Sample quantity requirements vary by laboratory and method and are not consistently published. Laboratories specify quantities at the quoting stage.
Marketplace policies now shape how brands source potency testing. BSCG and laboratory providers report that Amazon requires dietary supplement sellers to provide either a Certificate of Analysis from an ISO/IEC 17025 accredited laboratory or verification through an approved third-party certifier. BSCG's Amazon dietary supplement testing resource describes two routes. Products in Certified Drug Free and Certified Quality move through Amazon's compliance process on a fast track. Brands outside certification can obtain the required label claim, contaminant, and active pharmaceutical ingredient panels through accredited laboratories.
For brands selling on Amazon, accredited potency testing is a condition of listing rather than an optional quality investment. Amazon's high-risk categories, which include sports nutrition, weight management, and joint health, must also meet the label claim tolerances in 21 CFR 101.36 and 101.9(g). Equivalent published policies for other retailers are not documented in the sources reviewed here.
Independent analyses continue to find gaps between declared and measured content. A published analysis cited in BSCG's Amazon compliance resource found that 17 of 30 immune-support products sold on Amazon had inaccurate labels, including undeclared components.
Potency problems also overlap with identity and contamination problems. A JAMA Network investigation of 30 weight-loss supplements, summarized by BSCG, found 25 inaccurate labels, seven products with hidden components, and 10 containing substances prohibited for military use. These findings illustrate why potency testing alone does not establish product quality. Identity confirmation and contaminant screening answer different questions, and BSCG Certified Quality requires all three.
Yes. Under 21 CFR Part 111, manufacturers must establish finished product specifications for strength and composition and verify them by testing each batch or a statistically justified subset of batches. The rule does not name specific instruments, but it requires scientifically valid methods and documentation of why each method is appropriate.
No consistent public price list exists for supplement potency assays. Providers quote per engagement, and the main cost drivers are the analyte, the matrix, the method, and any method development or validation the product requires.
Turnaround depends on whether an established method exists. BSCG's Certified Quality page lists 20 business days after sample receipt for testing; a brand's document readiness and GMP status determine the full certification timeline.
Only with documentation. Part 111 permits reliance on a supplier's COA when the firm has qualified the supplier and documented the basis for that reliance. Amazon and certification programs generally require results from an ISO/IEC 17025 accredited laboratory or an approved certifier.
Identity testing confirms that an ingredient is what the label says it is. Potency testing measures how much of that ingredient is present. An ingredient can pass identity and fail potency, or deliver the right amount of the wrong material. Both tests are required under Part 111, and identity testing applies to every incoming dietary ingredient lot.
The laboratory reports an out-of-specification result and the brand investigates. Causes include formulation error, ingredient degradation, mixing problems, or a method that does not suit the matrix. Under 21 CFR 111.113, quality control personnel must conduct a material review, reject the batch unless they approve a permitted treatment or reprocessing, and document the decision.
Supplement potency testing is accessible for the large share of ingredients that have published methods. Accredited laboratories run established assays for vitamins, minerals, amino acids, fatty acids, and common botanical markers on routine timelines, and certification programs bundle that testing with contaminant screening and documentation review. The barriers concentrate in a smaller set of products: novel botanicals, complex blends, live probiotics, and ingredients without reference standards or published methods.
For those products, obtaining a result is possible but requires method development, matrix-specific validation, and a larger budget. In every case, the regulatory obligation extends beyond obtaining a number. The brand must show that the method is scientifically valid for its product and that the result supports the specification. Testing that is easy to buy is only useful when it is also fit for purpose.
YouTube Channel
Oliver Catlin Interview
BSCG BLOG
21 CFR 111 or ANSI 455-2: Which Matters More for Sports Nutrition Supplements?
The Catlin Perspective blog widget
THE HISTORY OF BSCG